Septerna (SEPN) Return on Capital Employed (2024 - 2026)

Septerna's quarterly Return on Capital Employed came in at 0.47% in Q1 2026, up 2146.0% year-on-year from 0.02% in Q1 2025, and up 123.32% quarter-over-quarter from 1.99% in Q4 2025.

Septerna has reported Return on Capital Employed for 3 years, with the latest figure at 0.47% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Capital Employed rose 2146.0% year-over-year to 0.47%; the trailing twelve-month figure through Mar 2026 stood at 0.47% (up 2146.0% YoY), and the FY2025 full-year result was 2.34%, up 2644.0% from the prior year.
  • Return on Capital Employed for Q1 2026 stood at 0.47%, up from 1.99% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.47% in Q1 2026, with the low at 26.71% in Q4 2024.
  • Average Return on Capital Employed over 3 years is 15.31%, with a median of 19.33% recorded in 2025.
  • Year-over-year, Return on Capital Employed soared 2472 bps in 2025 and surged 2146 bps in 2026.
  • Tracing SEPN's Return on Capital Employed over 3 years: stood at 26.71% in 2024, then soared by 93 bps to 1.99% in 2025, then soared by 123 bps to 0.47% in 2026.
  • The last three Return on Capital Employed figures came in at 0.47% (Q1 2026), 1.99% (Q4 2025), and 17.67% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 450.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 51.73%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -107.40%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 21.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.19%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.34%
10 Septerna 1.34 Bn 1.34 Bn - 0.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.47%
Dec 31, 2025 -1.99%
Sep 30, 2025 -17.67%
Jun 30, 2025 -24.95%
Mar 31, 2025 -20.99%
Dec 31, 2024 -26.71%